Want to track 9969 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
InnoCare Pharma Ltd. (9969) Statistics
Valuation metrics
Market Cap 29.31B
Enterprise value 12.11B
Trailing P/E (ttm) 20.84
Forward P/E 106.5
PEG ratio 0.04
Price/Sales (ttm) 5.87
Price/Book (mrq) 2.49
Enterprise Value/Revenue 4.4
Enterprise Value/EBITDA 14.47
Overview
Shares outstanding 1.76B
Float 1.17B
Shares short -
% Held by insiders 0.2%
% Held by institutions 0.39%
Average volume (10 days) 11.32M
Average volume (90 days) 8.33M
Price summary
52-Week low 9.65
52-Week high 20.18
Beta 0.35
50-Day moving average 14.64
200-Day moving average 13.54
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2024
Profitability
Profit margin 0.33%
Operating margin 0.28%
Operational effectiveness
Return on assets 0.08%
Return on equity 0.12%
Income Statement
Revenue (ttm) 2.9B
Revenue per share (ttm) 1.56
Quarterly revenue growth (yoy) 0.39%
Gross profit (ttm) 2.65B
EBITDA 721.58M
Net income to common (ttm) 841.08M
Diluted EPS (ttm) 0.51
Quarterly earnings growth (yoy) 4.89%
Balance Sheet
Total cash (mrq) 8.17B
Total cash per share (mrq) 4.74
Total debt (mrq) 2.08B
Total Debt/Equity (mrq) 0.29
Current ratio (mrq) 4.21%
Book value per share (mrq) 4.53
Cash Flow
Cash flow statement 36.39M
Levered free cash flow (LFCF) 341.86M
2026 © Marketlog. All Rights Reserved.
